Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction
- PMID: 8021206
- PMCID: PMC205630
- DOI: 10.1128/jb.176.14.4204-4209.1994
Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction
Abstract
Glycerol monolaurate (GML) is a naturally occurring surfactant that is used widely as an emulsifier in the food and cosmetics industries and is generally regarded as lacking in important biological activities. The recent observation that it inhibits the production of staphylococcal toxic shock toxin-1 (P. M. Schlievert, J. R. Deringer, M. H. Kim, S. J. Projan, and R. P. Novick, Antimicrob. Agents Chemother. 36:626-631, 1992) is therefore rather surprising and raises the interesting question of how such a compound might interact with cells. In this report, we show that GML inhibits the synthesis of most staphylococcal toxins and other exoproteins and that it does so at the level of transcription. We find that GML blocks the induction but not the constitutive synthesis of beta-lactamase, suggesting that it acts by interfering with signal transduction.
Similar articles
-
The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.J Antimicrob Chemother. 1994 Jan;33(1):41-55. doi: 10.1093/jac/33.1.41. J Antimicrob Chemother. 1994. PMID: 8157573
-
Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.Clin Infect Dis. 2009 Dec 1;49(11):1711-7. doi: 10.1086/644614. Clin Infect Dis. 2009. PMID: 19863450 Clinical Trial.
-
Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis.J Bacteriol. 1998 Jan;180(1):182-5. doi: 10.1128/JB.180.1.182-185.1998. J Bacteriol. 1998. PMID: 9422612 Free PMC article.
-
Regulation and control of toxic shock syndrome toxin 1: overview.Rev Infect Dis. 1989 Jan-Feb;11 Suppl 1:S142-4. Rev Infect Dis. 1989. PMID: 2648538 Review. No abstract available.
-
Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology.Chem Immunol. 1992;55:1-35. Chem Immunol. 1992. PMID: 1418613 Review. No abstract available.
Cited by
-
Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus.J Bacteriol. 2000 May;182(9):2668-71. doi: 10.1128/JB.182.9.2668-2671.2000. J Bacteriol. 2000. PMID: 10762277 Free PMC article.
-
Menaquinone analogs inhibit growth of bacterial pathogens.Antimicrob Agents Chemother. 2013 Nov;57(11):5432-7. doi: 10.1128/AAC.01279-13. Epub 2013 Aug 19. Antimicrob Agents Chemother. 2013. PMID: 23959313 Free PMC article.
-
Monolaurin Confers a Protective Effect Against Porcine Epidemic Diarrhea Virus Infection in Piglets by Regulating the Interferon Pathway.Front Immunol. 2022 Jan 13;12:797476. doi: 10.3389/fimmu.2021.797476. eCollection 2021. Front Immunol. 2022. PMID: 35095875 Free PMC article.
-
Requirement of the agr locus for colony spreading of Staphylococcus aureus.J Bacteriol. 2011 Mar;193(5):1267-72. doi: 10.1128/JB.01276-10. Epub 2010 Dec 17. J Bacteriol. 2011. PMID: 21169484 Free PMC article.
-
In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus.Sci Rep. 2021 Jan 8;11(1):177. doi: 10.1038/s41598-020-80481-0. Sci Rep. 2021. PMID: 33420288 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources